References
Al-Alwan, I., Navarro, O., Daneman, D., et al. (1999). Clinical utility of adrenal ultrasonography in the diagnosis of congenital adrenal hyperplasia. Journal of Pediatrics, 135, 71–75.
American Academy of Pediatrics Ad Hoc Writing Committee, 2000–2001. (2000). Technical Report: Congenital adrenal hyperplasia. Pediatrics 106, 1511–1518.
Antal, Z., & Zhou, P. (2009). Congenital adrenal hyperplasia: Diagnosis, evaluation, and management. Pediatrics in Review, 30, e49–e57.
Bose, H. S., Sugawara, T., Strauss, J. F., III, et al. (1996). The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. The New England Journal of Medicine, 355, 1970–1978.
Chen, H. (1986). Genetic disorders. In Paul I. Liu (Ed.), Blue book of diagnostic tests (pp. 421–462). Philadelphia, PA: W. B. Saunders.
Chertin, B., Hadas-Halpern, I., Fridmans, A., et al. (2000). Transabdominal pelvic sonography in the preoperative evaluation of patients with congenital adrenal hyperplasia. Journal of Clinical Ultrasound, 28, 122–124.
Clayton, P. E., Miller, W. L., & Oberfield, S. E. (2002). Concensus statement on 21-hydroxylase deficiency from the European Society of Pediatric Endocrinology and the lawson Wilkins Paediatric Endocrine Society. Hormone Research, 58, 188–195.
Cutler, G. B., Jr., & Laue, L. (1990). Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. The New England Journal of Medicine, 323, 1806–1813.
David, M., & Forest, M. G. (1984). Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. Journal of Pediatrics, 105, 799–803.
Deaton, M. A., Glorioso, J. E., & Mclean, D. B. (1999). Congenital adrenal hyperplasia: Not really a zebra. American Family Physician, 59, 1190–1196.
Deneux, C., Tardy, V., Dib, A., et al. (2001). Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 86, 207–213.
Forest, M. G., Morel, Y., & David, M. P. (1998). Prenatal treatment of congenital adrenal hyperplasia. Trends in Endocrinology and Metabolism, 9, 284–289.
Garner, P. R. (1998). Congenital adrenal hyperplasia in pregnancy. Seminars in Perinatology, 22, 446–456.
Hall, C. M., Jones, J. A., Meyer-Bahlburg, H. F., et al. (2004). Behavioral and physical masculinization are related to genotype in girls with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 89, 419–424.
Hoffman, W. H., Shin, M. Y., Donohoue, P. A., et al. (1996). Phenotypic evolution of classic 21-hydroxylase deficiency. Clinical Endocrinology, 45, 103–109.
Hughes, I. A. (1986). Clinical aspects of congenital adrenal hyperplasia: Early diagnosis and prognosis. Journal of Inherited Metabolic Disease, 9(Suppl 1), 115–123.
Hughes, I. A. (1988). Management of congenital adrenal hyperplasia. Archives of Disease in Childhood, 63, 1399–1404.
Hughes, I. A. (2002a). Congenital adrenal hyperplasia: 21-hydroxylase deficiency in the newborn and during infancy. Seminars in Reproductive Medicine, 20, 229–242.
Hughes, I. A. (2002b). Congenital adrenal hyperplasia: Phenotype and genotype. Journal of Pediatric Endocrinology & Metabolism, 15(Suppl 5), 1329–1340.
Hughes, I. A. (2002c). Intersex. BJU International, 90, 769–776.
Joint LWPES/ESPE CAH Working Group, Writing Committee. (2002). Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Journal of Clinical Endocrinology Metabolism 87, 4098–4053.
Kuttenn, F., Couillin, P., Girard, F., et al. (1985). Late-onset adrenal hyperplasia in hirsutism. The New England Journal of Medicine, 313, 224–231.
Lajic, S., Wedell, A., Bui, T. H., et al. (1998). Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. Trends in Endocrinology and Metabolism, 9, 284–289.
Levine, L. S. (2000). Congenital adrenal hyperplasia. Pediatrics in Review, 21, 159–170.
Lo, J. C., & Grumbach, M. M. (2001). Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia. Endocrinology and Metabolism Clinics of North America, 30, 207–229.
Merke, D. P., & Cutler, G. B. (1997). New approaches to the treatment of congenital adrenal hyperplasia. JAMA, 277, 1073–1076.
Meyer-Bahlburg, H. F. (2001). Gender and sexuality in classic congenital adrenal hyperplasia. Endocrinology and Metabolism Clinics of North America, 30, 155–171.
Miller, W. L. (1998). Molecular biology of steroid hormone synthesis. Endocrine Reviews, 9, 295–318.
Miller, W. L. (1999). Congenital adrenal hyperplasia in the adult patient. Advances in Internal Medicine, 44, 155–173.
New, M. I. (1995). Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia). The American Journal of Medicine, 98, 2S–8S.
New, M. I. (2001a). Antenatal diagnosis and treatment of congenital adrenal hyperplasia. Current Urology Reports, 2, 11–18.
New, M. I. (2001b). Prenatal treatment of congenital adrenal hyperplasia. The United States experience. Endocrinology and Metabolism Clinics of North America, 30, 1–13.
New, M. I., Carlson, A., Obeid, J., et al. (2001). Extensive personal experience. Prenatal diagnosis for congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 86, 5651–5657.
New, M. I., & Wilson, R. C. (2002). Genetic disorders of the adrenal gland, chapter 84. In D. L. Rimoin, J. M. Connor, R. E. Pyeritz, & B. R. Korf (Eds.), Emery and Rimoin’s principles and practice of medical genetics (4th ed., Vol. 2, pp. 2277–2314).
Nimkarn, S., & New, M. I. (2010). 21-hydroxylse deficient congenital adrenal hyperplasia. GeneReviews. Retrieved August 24, 2010. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1171/
Pang, S. (1997). Congenital adrenal hyperplasia. Endocrinology and Metabolism Clinics, 26, 853–891.
Pang, S., & Shook, M. K. (1997). Current status of neonatal screening for congenital adrenal hyperplasia. Current Opinion in Pediatrics, 9, 419–423.
Pang, S., Wallace, M. A., Hofman, L., et al. (1988). Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics, 81, 866–874.
Ritzén, E. M. (1998). Prenatal treatment of congenital adrenal hyperplasia: A commentary. Trends in Endocrinology and Metabolism, 9, 293–295.
Ritzén, E. M. (2001). Prenatal dexamethasone treatment of fetuses at risk for congenital adrenal hyperplasia: Benefits and concerns. Seminars in Neonatology, 6, 357–362.
Schnitzer, J. J., & Donahoe, P. K. (2001). Surgical treatment of congenital adrenal hyperplasia. Endocrinology and Metabolism Clinics of North America, 30, 137–154.
Speiser, P. W. (2001). Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Endocrinology and Metabolism Clinics of North America, 30, 31–59.
Speiser, P. W., Dupont, B., Rubinstein, P., et al. (1985). High frequency of nonclassical steroid 21-hydroxylase deficiency. American Journal of Human Genetics, 37, 650–667.
Speiser, P. W., & New, M. I. (1994). Prenatal diagnosis and management of congenital adrenal hyperplasia. Clinics in Perinatology, 21, 631–645.
Speiser, P. W., & White, P. C. (2003). Congenital adrenal hyperplasia. The New England Journal of Medicine, 349, 776–788.
Stikkelbroeck, N. M., Hermus, A. R., Braat, D. D., et al. (2003). Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Obstetrical and Gynecological Survey, 58, 275–284.
Therrell, B. L. (2001). Newborn screening for congenital adrenal hyperplasia. Endocrinology and Metabolism Clinics, 30, 15–30.
Therrell, B. L. J., Berenbaum, S. A., Manter-Kapanke, V., et al. (1998). Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics, 101, 583–590.
Wedell, A. (1996). Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia. Clinics in Laboratory Medicine, 16, 125–137.
Wedell, A. (1998). Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): Implications for diagnosis, prognosis and treatment. Acta Paediatrica, 87, 159–164.
White, P. C. (2001). Congenital adrenal hyperplasias. Best Practice & Research. Clinical Endocrinology & Metabolism, 15, 17–41.
White, P. C. (2009). Neonatal screening for congenital adrenal hyperplasia. Nature Review Endocrinology, 5, 490–498.
White, P. C., New, M. I., & Dupont, B. (1987a). Congenital adrenal hyperplasia. (first of two parts). The New England Journal of Medicine, 316, 1519–1524.
White, P. C., New, M. I., & Dupont, B. (1987b). Congenital adrenal hyperplasia (second of two parts). The New England Journal of Medicine, 316, 1580–1586.
White, P. C., & Speiser, P. W. (2000). Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews, 21, 245–291.
Wilson, T. (2004). Congenital adrenal hyperplasia. Emedicine. http://www.emedicine.com
Woelfle, J., Hoepffner, W., Sippell, W. G., et al. (2002). Complete virilization in congenital adrenal hyperplasia: Clinical course, medical management and disease-related complications. Clinical Endocrinology, 56, 231–238.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this entry
Cite this entry
(2012). Congenital Adrenal Hyperplasia. In: Chen, H. (eds) Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1037-9_48
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1037-9_48
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1036-2
Online ISBN: 978-1-4614-1037-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences